Featured Research

from universities, journals, and other organizations

Enzyme May Hold Key To New Treatment Of Diabetic Kidney Disease

Date:
November 14, 2006
Source:
Northwestern University
Summary:
Northwestern University researchers have found an enzyme, called "ACE2," may hold the potential to treat diabetic kidney disease, the most common form of kidney disease. The researchers have found low levels of the ACE2 enzyme in kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease.

Northwestern University Feinberg School of Medicine researchers have found that an enzyme called ACE2 may hold the potential to treat diabetic kidney disease, the most common form of kidney disease.

Related Articles


In the laboratory, researchers led by Daniel Batlle, professor of medicine in the Feinberg School, chief of the nephrology/hypertension division and staff nephrologist at Northwestern Memorial Hospital, have found low levels of the ACE2 enzyme in the glomeruli of the kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease from developing, Batlle said.

The experiments appear in a report by Ye et. al in the November issue of the Journal of the American Society of Nephrology.

Diabetes, which affects 230 million people worldwide and 21 million in the United States, is the leading cause of kidney failure. About one-third of patients with diabetes will go on to develop kidney disease. In diabetes, the small blood vessels in the kidneys are injured and the kidneys cannot clean the blood properly. In 2002, a total of 153,000 people in the U.S. with kidney failure due to diabetes were living on chronic dialysis or with a kidney transplant.

ACE inhibitors are currently used to treat kidney disease, said Batlle, the Earle, del Greco, and Levin Professor of Nephrology/Hypertension. "An eventual ACE2 therapy, perhaps combined with ACE inhibitors could be doubly effective," he said.

"This is a new frontier," said Batlle. "Targeting the ACE2 enzyme may be important, much in the same way as the introduction of ACE inhibitors two decades ago to treat high blood pressure and slow the progression of kidney disease."

In an editorial that accompanies the publication by Ye et al., Dr. Julie Ingelfinger writes, "The most important aspect of the Ye et al. report is that the work assessed the effect of an ACE2 antagonist, with or without an angiotensin receptor blocker. The ACE2 increased urinary albumin excretion in diabetic animals, but not in control animals. What of ACE2 and the development of therapies? In their article, Ye et al. suggest that ACE2 may regulate the levels of Ang- II within the glomulerulus by degrading it to Ang 1-7, a suggestion supported by the known actions of the enzyme. Such actions provide a rationale for embarking on strategies that might increase ACE2 in diabetes."


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Enzyme May Hold Key To New Treatment Of Diabetic Kidney Disease." ScienceDaily. ScienceDaily, 14 November 2006. <www.sciencedaily.com/releases/2006/11/061108102843.htm>.
Northwestern University. (2006, November 14). Enzyme May Hold Key To New Treatment Of Diabetic Kidney Disease. ScienceDaily. Retrieved December 17, 2014 from www.sciencedaily.com/releases/2006/11/061108102843.htm
Northwestern University. "Enzyme May Hold Key To New Treatment Of Diabetic Kidney Disease." ScienceDaily. www.sciencedaily.com/releases/2006/11/061108102843.htm (accessed December 17, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, December 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com
When You Lose Weight, This Is Where The Fat Goes

When You Lose Weight, This Is Where The Fat Goes

Newsy (Dec. 17, 2014) Can fat disappear into thin air? New research finds that during weight loss, over 80 percent of a person's fat molecules escape through the lungs. Video provided by Newsy
Powered by NewsLook.com
Flu Outbreak Closing Schools in Ohio

Flu Outbreak Closing Schools in Ohio

AP (Dec. 17, 2014) A wave of flu illnesses has forced some Ohio schools to shut down over the past week. State officials confirmed one pediatric flu-related death, a 15-year-old girl in southern Ohio. (Dec. 17) Video provided by AP
Powered by NewsLook.com
Yoga Could Be As Beneficial For The Heart As Walking, Biking

Yoga Could Be As Beneficial For The Heart As Walking, Biking

Newsy (Dec. 17, 2014) Yoga can help your weight, blood pressure, cholesterol and heart just as much as biking and walking does, a new study suggests. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins